Cancel
Apex Labs
See Linkedin
Apex Labs Employees
8 people indexed:
-
dtuk9@tjhj64qw.31y Sign up to see email
-
hv@q68i0541.7z8 Sign up to see email
-
uu@205u5z0n.w12 Sign up to see email
-
23h5@dw2dd5wk.0nh Sign up to see email
-
2rz@93zyt9n5.wyt Sign up to see email
-
inh@vu932zv7.njf Sign up to see email
-
0z8@nnfkj8g6.yvr Sign up to see email
-
3jf1w@fn6dw64k.kj8 Sign up to see email
Apex Labs Company Information
Apex Labs is a biopharmaceutical company based in Vancouver, BC, Canada, focused on the development and commercialization of psilocybin-based treatments. The company’s mission is to replace traditional antidepressants with its psilocybin treatments for managing depression and PTSD. As a licensed dealer of psilocybin, Apex Labs conducts extensive clinical programs to evaluate the safety and efficacy of its drug assets. It offers two primary drug candidates: APEX-52, designed for take-home dosing, and APEX-90, intended for in-clinic use. Apex Labs is particularly committed to supporting veteran patient communities, often prioritizing them in clinical trials and Early Access Programs. Following the completion of a phase 2b study in Canada, the company is actively seeking commercial approval in multiple regions including the US, Canada, UK, EU, and Australia. Notably, Apex Labs has completed the largest take-home microdose psilocybin clinical trial approved by Health Canada and has also received a Dealer’s Licence from Health Canada to distribute psilocybin.
Report inaccurate information
Report inaccurate information
